164 related articles for article (PubMed ID: 37137547)
1. Anti-Yo paraneoplastic cerebellar degeneration in a patient with stage IV ovarian adenocarcinoma during bevacizumab maintenance therapy.
Giucca A; Morrison H; Wilson T; Cossburn M
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37137547
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
Saeed DB; Gupta L
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
Zouiten O; Benbrahim Z; Amaadour L; Mellas N
Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
Liu S; Tunkel R; Lachmann E; Nagler W
Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
Le May M; Dent S
Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
[TBL] [Abstract][Full Text] [Related]
10. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.
Sahoo D; Dey A; Dash A; Dash A
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272525
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report.
Elomrani F; Ouziane I; Boutayeb S; Bensouda Y; Mrabti H; Errihani H
Pan Afr Med J; 2014; 18():2. PubMed ID: 25360186
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
13. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report.
Cui D; Xu L; Li WY; Qian WD
Medicine (Baltimore); 2017 Aug; 96(32):e7362. PubMed ID: 28796031
[TBL] [Abstract][Full Text] [Related]
14. A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.
Marchand V; Graveleau J; Lanctin-Garcia C; Bourbouloux E; Bridji B; Resche I; Kraeber-Bodéré F; Rousseau C
Gynecol Oncol; 2007 May; 105(2):545-7. PubMed ID: 17368524
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
Lin JT; Lachmann E; Nagler W
J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
[TBL] [Abstract][Full Text] [Related]
16. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
[TBL] [Abstract][Full Text] [Related]
17. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
Key RG; Root JC
Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
[TBL] [Abstract][Full Text] [Related]
18. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
[TBL] [Abstract][Full Text] [Related]
20. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
Bruhnding A; Notch D; Beard A
J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
